Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,326,457
+$7,026,212 QoQ
Shares Held
817,685
+1542.2% QoQ
Ownership
0.485%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,382,181,502 across 180 Biotechnology names. VIR ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in VIR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,326,457 | 817,685 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $300,245 | 49,792 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $191,422 | 33,524 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $182,734 | 36,257 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,283,441 | 506,704 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,684,679 | 502,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,970,605 | 930,655 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,210,730 | 922,554 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,546,552 | 646,254 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,737,588 | 769,144 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,247,764 | 880,231 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,313,213 | 53,535 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,566,071 | 67,300 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,138,823 | 44,995 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $285,691 | 14,818 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $218,736 | 8,588 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,343,355 | 52,230 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,062,859 | 144,802 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,273,323 | 167,126 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,365,099 | 219,228 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,962,290 | 116,292 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $577,671 | 21,571 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||